This is the first of the three-part podcast series, Keeping up with the Chemos on Trametinib. After going over some general information on Trametinib including mutation status considerations, baseline lab testing, ocular toxicity, and line of therapy. The multidisciplinary panel will discuss dosing and drug preparation for giving Trametinib. The session wraps up with some key take home points on Trametinib.

2023-2024 SGO Chemotherapy and Targeted Therapies Subcommittee Members and Moderators:
Tracilyn Hall, MD
Jennifer MacDonald, PharmD, BCOP

Speakers:
Christina M. Davis, PharmD, BCOP
David M. Gershenson, MD 
Rebecca L. Porter, MD, PhD